Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Citius Oncology Inc. > Profile

Citius Oncology Inc. (CTOR)

Market is closed
Sector: Pharmaceutical Preparations

Insider Roster

Show All Insiders (17)
News See All
Citius Oncology (CTOR) Expands LYMPHIR Distribution to Europe Through Exclusive Agreement With Uniphar

Citius Oncology (CTOR) Expands LYMPHIR Distribution to Europe Through Exclusive Agreement With Uniphar

Citius Oncology Inc. (NASDAQ:CTOR) is one of the most undervalued penny stocks to buy right now.

Keep Reading →

February 24th, 2026 - News

11 Most Undervalued Penny Stocks to Buy Right Now

11 Most Undervalued Penny Stocks to Buy Right Now

Earlier on January 27, Matt Stucky from Northwestern Mutual joined CNBC's 'Closing Bell Overtime' to discuss a shifting market landscape where investor focus is broadening beyond mega-cap stocks.

Keep Reading →

February 24th, 2026 - Hedge Funds News

Click here to See All News
Insider Monkey Quarterly Strategy
+599.2% Insider Monkey Quarterly Strategy
+227% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
500%
250%
0%

Returns since its inception in May 2014 (through June 2, 2026)

Subscribe Now

30 day money back guarantee. Cancel anytime.

Past performance does not guarantee future returns. Click to see how the portfolio is constructed.